semaglutide elisa cross-reactivity liraglutide Frontiers Representative chromatograms of liraglutide (left)

In November 2024, the Food and Drug Administration (FDA) issued Compounding and the FDA: Questions and Answers, warning that Compounded drugs should only be used in patients whose [...]

Retatrutide handles appetite, digestion, and systemic metabolism

Novo filed the patent suit two days later, on February 9

Reach out to us online or call 866-833-1822 to find out more about how we can support you.

Multiple clinical trials have demonstrated semaglutide's beneficial effects on markers of insulin sensitivity, though it is important to note that the medication is not specifically FDA-approved for treating insulin resistance as a standalone indication